Use of 1,2,4-dithiazolidine-3,5-dione (DtsNH) and 3-ethoxy-1,2,4-dithiazoline-5-one (EDITH) for synthesis of
phosphorothioate-containing oligodeoxyribonucleotides
Use of 1,2,4-dithiazolidine-3,5-dione (DtsNH) and 3-ethoxy-1,2,4-dithiazoline-5-one (EDITH) for synthesis of phosphorothioate-containing oligodeoxyribonucleotides
Qinghong
Xu
,
Karin
Musier-Forsyth
,
Robert P.
Hammer
1
and
George
Barany*
Department of Chemistry, University of Minnesota, 207 Pleasant Street S.E.,
Minneapolis
, MN 55455-0431,
USA
and
1
Department of Chemistry, Louisiana State University, 232 Choppin Hall,
Baton Rouge
, LA 70803-1804,
USA
Received February 13, 1996;
Accepted March 18, 1996
ABSTRACT
Previous methods for the preparation of phosphorothioate-containing oligodeoxyribonucleotides rely on the reaction of phosphite
triesters with sulfurizing reagents such as tetraethylthiuram disulfide (TETD)
and 3
H
-1,2-benzodithiol-3-one 1,1-dioxide (Beaucage reagent). However, these and
other sulfurizing reagents suffer from several disadvantages, and there is
great impetus for the development of improved methods for sulfur transfer that
are fully compatible with standard automated DNA synthesis. The present report
describes the use of 1,2,4-dithiazolidine-3,5-dione (DtsNH) and 3-ethoxy-1,2,4-dithiazoline-5-one (EDITH) as effective
sulfurizing reagents that meet these needs. Both reagents are easily prepared,
and are stable upon prolonged room temperature storage in acetonitrile
solution. The reagents are used at low concentrations (0.05 M) and for short
reaction times (30 s). The methodology has been proven for the automated
synthesis on 0.2-1.0 [mu]mol scales of oligodeoxyribonucleotides, of length 6-20 bases, containing the phosphorothioate substitution at either a single
site or at all positions.
INTRODUCTION
Phosphorothioate analogues of the phosphate moiety are of considerable interest
in nucleic acid research (
1
-
3
). For example, phosphorothioate-containing antisense oligonucleotides have been used
in vitro
and
in vivo
as inhibitors of gene expression (
4
-
7
). Site-specific attachment of reporter groups onto the DNA or RNA backbone is
facilitated by the incorporation of single phosphorothioate moieties (
8
,
9
). Phosphorothioates have also been introduced into oligonucleotides for
mechanistic studies on DNA-protein (
10
) and RNA-protein (
11
) interactions, as well as catalytic RNAs (
12
).
Introduction of phosphorothioate moieties into oligonucleotides, assembled by
solid-phase synthesis, can be achieved readily in two ways. The H-phosphonate approach involves a single sulfur transfer step, carried
out after the desired sequence has been assembled, to convert all of the
internucleotide linkages to phosphorothioates (
13
-
15
). Alternatively, the phosphoramidite approach features a choice at each
synthetic cycle: a standard oxidation provides the normal phosphodiester
internucleotide linkage, whereas a sulfurization step introduces a
phosphorothioate at that specific position in the sequence (
16
,
17
). An advantage of using phosphoramidite chemistry, therefore, is the capability
to control the state of each linkage [P=O versus P=S] in a site-specific manner. The earliest studies to create phosphorothioates used
elemental sulfur (
17
), but the success of the phosphoramidite approach is dependent on the
availability and application of more efficient, more soluble sulfur transfer
reagents that are compatible with automated DNA synthesis.
With these goals in mind, a number of reagents have been designed and tested in
recent years. These include 3
H
-1,2-benzodithiol-3-one 1,1-dioxide (Beaucage reagent;
18
), tetraethylthiuram disulfide (TETD;
19
), phenylacetyl disulfide (
20
), dibenzoyl tetrasulfide (
21
), bis(
O
,
O
-diisopropoxy phosphinothioyl) disulfide (S-Tetra;
22
), benzyltriethylammonium tetrathiomolybdate (BTTM;
23
) and bis(4-methoxybenzenesulfonyl) disulfide and related aryl derivatives (
24
). Of the listed compounds, the Beaucage reagent has been used widely due to its
commercial availability and favorable kinetics and effectiveness. However, the
synthetic accessibility, solubility properties and stability of the Beaucage
reagent are not optimal, and its suitability for large-scale oligonucleotide preparation has been questioned (
22
,
24
). This paper describes 1,2,4-dithiazolidine-3,5-dione (DtsNH) and 3-ethoxy-1,2,4-dithiazoline-5-one (EDITH), both known
compounds [
25
-
28
; see Scheme
1
for structures and method of preparation], in a novel application to create
phosphorothioates. These new reagents appear to have an optimal combination of
properties that suggest they will be advantageous alternatives to existing
sulfurizing reagents.
MATERIALS AND METHODS
General
TETD was from Applied Biosystems (Foster City, CA), and the Beaucage reagent was
from Glen Research (Sterling, VA). EDITH, m.p. 49-51oC, and DtsNH, m.p. 141-142oC, were both white needles prepared by procedures that
are described in detail elsewhere (
28
); direct reaction of
O
-ethylthiocarbamate and (chlorocarbonyl)sulfenyl chloride gives EDITH in
63% yield, and treatment of EDITH with concentrated aqueous hydrochloric acid
gives DtsNH in overall 47% yield for two steps. Before use, acetonitrile
solutions of DtsNH, EDITH, TETD or the Beaucage reagent were placed over
activated 4 Å molecular sieves for 12 h. Eluents for chromatography were prepared
using deionized water, solvents and salts of the highest available grade.
Reversed-phase high performance liquid chromatography (RP-HPLC) analyses of fully deprotected, crude synthetic
oligodeoxyribonucleotides containing single phosphorothioate linkages were
performed using a Vydac analytical C
18
reversed-phase column (218TP54; 5 [mu]m, 300 Å; 0.46 * 25 cm;
29
) on a Beckman system monitored at 260 nm. Separation of crude oligodeoxyribonucleotides that were fully sulfurized was
achieved by ion-exchange HPLC using a Dionex NucleoPac PA-100 column (0.4 * 25 cm;
30
-
32
). A PE-Sciex API
III
triple quadrupole mass spectrometer was used for electrospray mass spectrometry
(ESMS;
33
,
34
) to analyze oligonucleotides either directly after synthesis, or after HPLC
fractionation.
31
P Nuclear magnetic resonance (NMR) spectroscopy was used to analyze further
phosphorothioate-containing oligodeoxyribonucleotides: fully deprotected material from 1.0 [mu]mol scale syntheses was dissolved in 0.6 ml of H
2
O, and spectra were recorded on a Varian VXR 300 MHz NMR spectrometer operating
at 121.4 MHz, and referenced to external 85% phosphoric acid.
13
C NMR spectra were recorded on the same Varian instrument operating at 75 MHz.
Solid-phase synthesis of phosphorothioate-containing oligodeoxyribonucleotides
A Pharmacia Gene Assembler Special DNA Synthesizer was operated on either a 0.2 or 1.0 [mu]mol scale, starting with controlled pore-glass (500 Å) supports loaded with the 3'-end deoxyA residue attached to the supports via a
long chain alkylamino linker (dA-lcaa-CPG), and using [beta]-cyanoethyl deoxyribonucleoside phosphoramidites and
other standard solvents and reagents, all from Glen Research. Conditions used
for sulfurization are described in the Tables. The typical sulfurizing reagent
volume used per cycle was 1.25 ml, regardless of the synthesis scale chosen.
However, identical results were achieved with 0.5 ml. The sulfurizing reagent
was recycled through the column at a flow rate of 2.5 ml/min during the
reaction times indicated in the Tables. The capping step in the synthesis cycle
was performed
after
the sulfurization reaction, in order to avoid premature oxidation of the
phosphite linkage (
18
). The remaining steps in the synthesis cycle were performed according to
standard methods (Pharmacia). Upon completion of solid-phase steps, the oligodeoxyribonucleotides were released from the support
and deblocked with 30% ammonium hydroxide (15 h, 55oC), desalted on C
18
Sep-Pak cartridges (Millipore), lyophilized, and analyzed by reversed-phase and/or ion-exchange HPLC, polyacrylamide gel electrophoresis, ESMS and
31
P NMR.
RESULTS AND DISCUSSION
Sulfurizations by DtsNH or EDITH
DtsNH (structure in Scheme
1
) is the simplest member (i.e., no substituent on nitrogen) of a family of
disulfide-containing five-membered heterocycles (
25
,
27
) that have been adapted for amino group protection (
27
,
35
-
40
). Dts is an acronym for dithiasuccinoyl, which emphasizes how the heterocycle
is viewed as an amine masked with two molecules of carbonyl sulfide (COS). The
parent amine is released when the heterocyclic disulfide is reduced by a
variety of agents including thiols and borohydrides (
27
,
35
-
40
). Dts-amines can also be viewed as masked isocyanates, a dissection that gives
rise to one molecule of COS as well as monomeric `sulfur' (
27
,
35
-
40
). A likely driving force for the various reactions of Dts-amines is the relief of strain in the five-membered heterocycle, as well as relief from the unfavorable
repulsion of unshared electron pairs of adjacent sulfurs (
37
,
38
,
38
).
The reaction of Dts-amines with simple trialkyl- and triarylphosphines is of particular interest: in the presence of
water, the disulfide is reduced, the amine forms, and the co-product is the corresponding phosphine oxide (
36
), whereas under anhydrous conditions, the isocyanate forms with the phosphine
sulfide as co-product (
39
-
41
). The present work shows how the latter chemistry can be `inverted', and used
to sulfurize the trivalent phosphorus [P(III)] intermediates that arise in the
phosphoramidite method of oligonucleotide synthesis (Scheme
2
, top). One point of focus of the current work is on DtsNH; other Dts
derivatives were also examined and the results of those studies will be
reported elsewhere. As a second point of focus, we have examined another
disulfide-containing five-membered heterocycle, EDITH, which is the synthetic precursor to
DtsNH (Scheme 1) and is similarly a planar molecule with the disulfide
constrained to the least favorable dihedral angle, i.e., 0oC (
28
). EDITH also reacts with the trivalent phosphorus intermediates to effect
sulfurization, providing COS and
O
-ethyl cyanate as co-products (Scheme 2, bottom). Finally, studies were carried out
comparing DtsNH and EDITH with two commercially available reagents, TETD and
the Beaucage reagent.
Synthesis of a model oligodeoxyribonucleotide hexamer containing a single
internal phosphorothioate linkage
Stabilities of DtsNH and EDITH
To determine the stabilities and solubilities of DtsNH and EDITH upon prolonged
storage in solution, 0.2 and 0.05 M solutions were prepared in CH
3
CN and stored at 25oC over 4 Å molecular sieves. During a 2 week period, these solutions were
tested periodically by RP-HPLC analysis (C
18
column developed at 1.2 ml/min with 0.1% aqueous TFA-CH
3
CN from 19:1 to 3:2 over 12 min, monitored at 254 nm). At both concentrations tested, the only peaks
observed were those of the compounds under evaluation, and the peak areas
remained entirely unchanged. In addition,
13
C NMR and
1
H NMR spectra in CD
3
CN were recorded after 1 month and compared with those of freshly prepared
solutions: no new peaks appeared. Moreover, the solutions remained clear and
colorless over 2 weeks. The solubility of the Beaucage reagent as a 0.05 M solution in CH
3
CN was evaluated similarly; already after 2 days, a significant precipitate occurred even when silanized bottles were used
according to the manufacturer's recommendations.
Figure 5
.
Both anion-exchange HPLC (conditions of Fig. 4) and
31
P NMR (insets) of the oligodeoxyribonucleotide S-d(CCTCTTCGCTATTACGCCAA) synthesized on a 1.0 [mu]mol scale, with multiple phosphorothioate linkages established by 30 s reactions with 0.05 M sulfurizing reagent in CH
3
CN. (
A
) Sulfurizations performed by EDITH; (
B
) sulfurizations performed by the Beaucage reagent.
We compared the sulfurization efficiency of freshly prepared EDITH and DtsNH
(0.05 M solution and 0.5 min reaction time) with that of 2- and 1-month old solutions respectively, in the synthesis of 5'-d(TTT
s
TTA)-3'. RP-HPLC analysis of crude product oligomers indicated that in
all cases >98% sulfur transfer efficiency was achieved. It is also worth comparing the favorable properties of DtsNH and EDITH found
here with those described for S-Tetra (
22
). The latter reagent was reported to give inferior oligonucleotide synthesis
results with solutions stored >1 week (
22
).
SUMMARY AND CONCLUSIONS
This paper reports new sulfurizing agents, DtsNH and EDITH, that are highly
effective for the establishment of phosphorothioate linkages in oligodeoxyribonucleotides. The reagents are relatively easy and inexpensive to prepare, and are stable in solution. Furthermore,
sulfurizations promoted by DtsNH and EDITH occur at low concentrations and with
short reaction times. This array of positive attributes augur well for the
significance of the DtsNH and EDITH reagents in nucleic acid research.
ACKNOWLEDGEMENTS
A portion of these results (preliminary studies with DtsNH) were reported in
preliminary form at the Fourteenth American Peptide Symposium, June 18-23, 1995, Columbus, Ohio.
We thank Dr James G. Coull (PerSeptive BioSystems) and anonymous referees for
constructive suggestions of additional experiments that have been carried out
and reported in the revised version of this paper. DtsNH and EDITH that were
used in some of these studies were prepared over a 20-year period by the following students and technicians: Lin Chen, Steven J.
Eastep, David A. Halsrud and Lydia Ong, in addition to two of the authors (G.B.
and R.P.H.). Finally, we are grateful to NIH grants GM 28934, 42722 and 43552
to G.B.; GM 49928 to K.M.F.; and grants LEQSF(RF/19931996)-RD-A-42 and NSF CHE-9500992 to R.P.H. for support of this research.
REFERENCES
1 Eckstein, F. and Gish, G. (1989) TIBS, 14, 97-100.
2 Zon, G. and Stec, W.J. (1991) In Eckstein, F. (ed.), Oligonucleotides and Analogues: A Practical Approach. IRL Press, Oxford, pp. 87-108.
3 Iversen, P. (1991) Anti-Cancer Drug Des., 6, 539-568.
4 Uhlmann, E. and Peyman, A. (1990) Chem. Rev., 90, 544-583.
5 Gao, W.-Y., Han, F.-S., Storm, C., Egan, W. and Cheng, Y.-C. (1992) Mol. Pharmacol., 41, 223-229.MEDLINE Abstract
15 Agrawal, S. and Tang, J.-Y. (1990) Tetrahedron Lett.,31, 7541-7544.
16 Stec, W.J., Zon, G., Egan, W. and Stec, B. (1984) J. Am. Chem. Soc., 106, 6077-6079.
17 Connolly, B.A., Potter, B.V.L., Eckstein, F., Pingoud, A. and Grotjahn, L. (1984) Biochemistry, 23, 3443-3453.MEDLINE Abstract
18 Iyer, R.P., Phillips, L.R., Egan, W., Regan, J.B. and Beaucage, S.L. (1990) J. Org. Chem., 55, 4693-4699.
19 Vu, H. and Hirschbein, B.L. (1991) Tetrahedron Lett., 32, 3005-3008.
20 Roelen, H.C.P.F., Kamer, P.C.J., van den Elst, H., van der Marel, G.A. and van Boom, J.H. (1991) Recl. Trav. Chim. Pays-Bas., 110, 325-331.
21 Rao, M.V., Reese, C.B. and Zhengyun, Z. (1992) Tetrahedron Lett., 33, 4839-4842.
22 Stec, W.J., Uznanski, B., Wilk, A., Hirschbein, B.L., Fearon, K.L. and Bergot, B.J. (1993) Tetrahedron Lett., 34, 5317-5320.
23 Rao, M.V. and Macfarlane, K. (1994) Tetrahedron Lett., 35, 6741-6744.
24 Efimov, V. A., Kalinkina, A. L., Chakhmakhcheva, O. G., Hill, T. S. and Jayaraman, K. (1995) Nucleic Acids Res.,23, 4029-4033.MEDLINE Abstract
25 Zumach, G. and Kühle, E. (1970) Angew Chem. Int. Ed. Engl.,9, 54-63.
26 Dahms, G., Haas, A. and Klug, W. (1971) Chem. Ber.,104, 2732-2742.
27 Barany, G. Ph.D. thesis (1977) The Rockefeller University, Dissertation Abstr., 38, 5893-B.
28 Chen, L., Thompson, T.R., Hammer, R.P. and Barany, G. (1996)submitted.
29 Wyrzykiewicz, T. K. and Cole, D. L. (1995) Bioorg. Chem., 23, 33-41.
30 Ausserer, W. A. and Biros, M. L. (1995) BioTechniques, 19, 136-139.MEDLINE Abstract
31 Sproat, B., Colonna, F., Mullah, B., Tsou, D., Andrus, A., Hampel, A. and Vinayak, R. (1995) Nucleoside Nucleotides,14, 255-273.
32 Bergot, B. J. (Mar. 7, 1995) U. S. Patent, 5, 395,928.
33 Little, D. P., Chorush, R. A., Speir, J. P., Senko, M. W., Kelleher, N. L. and McLafferty, F. W. (1994) J. Am. Chem. Soc., 116, 4893-4897.
34 Potier, N., Van Dorsselaer, A., Cordier, Y., Roch, O. and Bischoff, R. (1994) Nucleic Acids Res., 22, 3895-3903.MEDLINE Abstract
35 Barany, G. and Merrifield, R.B. (1977) J. Am. Chem. Soc.,99, 7363-7365.MEDLINE Abstract
36 Barany, G. and Merrifield, R.B. (1979) Anal. Biochem.,95, 160-170.MEDLINE Abstract
37 Barany, G. and Merrifield, R.B. (1980) J. Am. Chem. Soc.,102, 3084-3095.
39 Barany, G. (1982) Crystal Structure Commun., 11, 913-928.
40 Barany, G., Albericio, F., Chang, J.L., Ferrer, M., Hammer, R.P., Kneib-Cordonier, N., Ottinger, E.A. and Solé, N.A. (1992) ORGN 184. American Chemical Society, 203rd National Meeting, San Francisco, California, April 5-10, 1992.
41 Hammer, R.P. and Barany, G. (1987) American Chemical Society, 21st Great Lakes Regional Meeting, Chicago, Illinois, June 10-12, 1987.